Clinical Trial Update: A Study of Rituximab (MabThera) in Combination With Chemotherapy in Participants With CD20-Positive B-Cell Chronic Lymphocytic Leukemia

View source ↗

Summary

This study evaluated Rituximab in combination with chemotherapy for CD20-positive B-cell chronic lymphocytic leukemia and has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Rituximab (MabThera) (Rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Lymphocytic Leukemia, Chronic | Status: COMPLETED | Results posted: 2017-06-14